DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4+ T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo

Journal of Virology

Volumn 74, Issue 23, 2000, Pages 11173-11180

  Sin, J I ^a   Kim, J J ^a   Pachuk, C ^a   Satishchandran, C ^a   Weiner, D B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; COMPLEMENTARY DNA; DNA VACCINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMID DNA; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HERPES SIMPLEX VIRUS 2; IMMUNOMODULATION; IMMUNOTHERAPY; IN VIVO STUDY; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ANIMALS; CYTOKINES; FEMALE; HERPESVIRUS 2, HUMAN; HERPESVIRUS VACCINES; IMMUNOGLOBULIN G; INTERLEUKIN-8; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RANTES; TH1 CELLS; TH2 CELLS; VACCINES, DNA; VIRAL VACCINES;

EID: 0034467315     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.23.11173-11180.2000     Document Type: Article

References (49)

1. Human chemokines: An update
2. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines
3. DNA immunization against experimental genital herpes simplex virus infection
4. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant
5. A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D
6. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge
7. Noncytopathic clearance of lymphocyte choriomeningitis virus from the hepatocyte
8. Viral clearance without destruction of infected cells during acute HBV infection
9. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets
10. Interferon as an agent against herpes simplex virus
11. Pathogenesis of herpes simplex virus in B cell-suppressed mice: The relative roles of cell mediated and humoral immunity
12. Differential CC chemokine-induced enhancement of T helper cell cytokine production
13. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines
14. CD8 positive T-cells influence antigen-specific immune responses through the expression of chemokines
15. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease
16. Role of mucosal immunity in herpes simplex virus infection
17. The neutrophil activating factor (NAP-1) is also chemotactic for T lymphocytes
18. Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2
19. C-C chemokines differentially alter interleukin-4 production from lymphocytes
20. + T lymphocytes
21. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27
22. Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: Cytotoxic T cells
23. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2
24. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory, protein 1 alpha, or human interleukin 8
25. Herpes simplex virus type 1 glycoproteins gB, gC, and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes
26. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2
27. Human RANTES induces the migration of human T lymphocytes into the peripheral tissues of mice with severe combined immune deficiency
28. Immune mechanisms by which the spread of viral infections is stopped
29. Properties of the novel proinflammatory supergene "intercrine" cytokine family
30. Humoral and cellular immune responses to herpes simplex virus-2 glycoprotein D generated by facilitated DNA immunization of mice
31. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge
32. Chemokine receptors: Gateways to inflammation and infection
33. Latent infection of sensory ganglia with herpes simplex virus: Efficacy of immunization
34. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
35. Biology of the RANTES/SIS cytokine family
36. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
37. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens
38. Protection of mice from lethal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes
39. In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model
40. + T cell-mediated protective immunity against HSV-2 challenge
41. Protective immune correlates can segregate by vaccine type in a murine herpes model system
42. Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: Effect of co-injection with a granulocytemacrophage colony-stimulating factor gene
43. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production
44. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: Results of a placebo-controlled vaccine trial
45. Chemokines and T lymphocyte activation. I. Beta chemokines costimulate human T lymphocyte activation in vitro
46. Chemokines, inflammation and the immune system
47. + T cells in response to MIP-1α and MIP-1β
48. + CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled